Reinvigorating natural product combinatorial biosynthesis with synthetic biology

被引：0
作者：
Kim E. [1 ]
Moore B.S. [2 ,3 ]
Yoon Y.J. [1 ]
机构：
[1] Department of Chemistry and Nano Science, Ewha Womans University, Seoul
[2] Scripps Institution of Oceanography, University of California at San Diego, San Diego, CA
[3] Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California at San Diego, San Diego, CA
来源：
Nature Chemical Biology | 2015年 / 11卷 / 9期
基金：
美国国家卫生研究院; 新加坡国家研究基金会;
关键词：
D O I：
10.1038/nchembio.1893
中图分类号：
学科分类号：
摘要：
Natural products continue to play a pivotal role in drug-discovery efforts and in the understanding if human health. The ability to extend nature's chemistry through combinatorial biosynthesis - altering functional groups, regiochemistry and scaffold backbones through the manipulation of biosynthetic enzymes - offers unique opportunities to create natural product analogs. Incorporating emerging synthetic biology techniques has the potential to further accelerate the refinement of combinatorial biosynthesis as a robust platform for the diversification of natural chemical drug leads. Two decades after the field originated, we discuss the current limitations, the realities and the state of the art of combinatorial biosynthesis, including the engineering of substrate specificity of biosynthetic enzymes and the development of heterologous expression systems for biosynthetic pathways. We also propose a new perspective for the combinatorial biosynthesis of natural products that could reinvigorate drug discovery by using synthetic biology in combination with synthetic chemistry.
引用
收藏
页码：649 / 659
页数：10
相关论文
共 98 条
  • [1] Hopwood D.A., Et al., Production of 'hybrid' antibiotics by genetic engineering, Nature, 314, pp. 642-644, (1985)
  • [2] Newman D.J., Cragg G.M., Natural products as sources of new drugs over the 30 years from 1981 to 2010, J. Nat. Prod., 75, pp. 311-335, (2012)
  • [3] Robles O., Romo D., Chemo-and site-selective derivatizations of natural products enabling biological studies, Nat. Prod. Rep., 31, pp. 318-334, (2014)
  • [4] Li J.W., Vederas J.C., Drug discovery and natural products: End of an era or an endless frontier?, Science, 325, pp. 161-165, (2009)
  • [5] Huang K.X., Xia L., Zhang Y., Ding X., Zahn J.A., Recent advances in the biochemistry of spinosyns, Appl. Microbiol. Biotechnol., 82, pp. 13-23, (2009)
  • [6] Hertweck C., The biosynthetic logic of polyketide diversity, Angew. Chem. Int. Edn Engl., 48, pp. 4688-4716, (2009)
  • [7] Schwarzer D., Finking R., Marahiel M.A., Nonribosomal peptides: From genes to products, Nat. Prod. Rep., 20, pp. 275-287, (2003)
  • [8] McDaniel R., Et al., Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products, Proc. Natl. Acad. Sci. USA, 96, pp. 1846-1851, (1999)
  • [9] McDaniel R., Ebert-Khosla S., Hopwood D.A., Khosla C., Engineered biosynthesis of novel polyketides, Science, 262, pp. 1546-1550, (1993)
  • [10] Nguyen K.T., Et al., Combinatorial biosynthesis of novel antibiotics related to daptomycin, Proc. Natl. Acad. Sci. USA, 103, pp. 17462-17467, (2006)
12345678910